ArticleJournal of acquired immune deficiency syndromes (1999)2025
Adults Aged ≥50 Years Reached by the CDC's HIV Programs Including HIV Testing, PrEP Referrals, and Linkage to Care in the United States, Puerto Rico, and the US Virgin Islands, 2019-2022.
Article in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Focusing on vulnerable populations in HIV.Chinese medical journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionOlder adults (defined as adults who are 50 and over) accounted for 1 in 6 persons newly diagnosed with HIV in 2022. The objectives of this analysis were to present the most currently available data about older adults reached by the Centers for Disease Control and Prevention's (CDC) HIV programs.
methodsFrom 2019 through 2022, CDC funded 61 health departments and 160 community-based organizations in the United States and Puerto Rico and the US Virgin Islands to provide HIV testing, preexposure prophylaxis (PrEP) referrals, and linkage to HIV medical care and report on their program outcomes to CDC. We conducted descriptive analysis and multivariable robust Poisson regression analysis to assess the association between demographic characteristics and outcomes of HIV tests among older adults.
resultsBetween 2019 and 2022, the percentage of CDC-funded HIV tests provided to older adults increased (16.9% in 2019, 17.3% in 2020, 18.3% in 2021, and 18.4% in 2022). In 2022, older adults accounted for 11% of new diagnoses. Among those (876), 779 people had linkage data, and of those, 579 (74.1%) were linked to HIV medical care within 30 days after diagnosis. Of those older adults with a negative test result and available data, 90,422 (41.3%) were eligible for a PrEP referral and 39,382 (44.3%) were referred to a PrEP provider. DISCUSSION: Continued efforts are needed to provide focused HIV prevention messaging specifically for older adults and to make available relevant information about HIV to health care providers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.